Deciphera Pharmaceuticals, Inc. DCPH
25.59 +25.59
Day range unavailable
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 163.36M | 134.04M | 96.15M | 42.09M | 25.00M | |
| 159.62M | 125.27M | 93.22M | 41.86M | 25.00M | |
| -210.96M | -182.72M | -300.08M | -271.19M | -200.73M | |
| -194.94M | -178.93M | -299.96M | -266.49M | -192.26M | |
| -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 83.51M | 64.74M | 87.06M | 135.90M | 120.32M | |
| 473.57M | 454.04M | 429.48M | 642.43M | 622.41M | |
| 122.65M | 112.35M | 124.76M | 98.76M | 75.94M | |
| 25.88M | 29.11M | 30.86M | 31.22M | 17.65M | |
| 350.92M | 341.69M | 304.72M | 543.68M | 546.47M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -146.70M | -152.86M | -240.82M | -239.68M | -149.30M | |
| 12.55M | -34.31M | 176.85M | 28.46M | -460.52M | |
| 152.00M | 164.99M | 14.89M | 226.80M | 436.37M | |
| -778.00K | -841.00K | -1.97M | -5.31M | -4.93M | |
| 17.86M | -22.18M | -49.09M | 15.58M | -173.44M |